MedMira Inc
OTC:MMIRF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/OCF
Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.
Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.
Valuation Scenarios
If EV/OCF returns to its Industry Average (14.9), the stock would be worth $-0.02 (156% downside from current price).
| Scenario | EV/OCF Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -26.6 | $0.04 |
0%
|
| Industry Average | 14.9 | $-0.02 |
-156%
|
| Country Average | 11.9 | $-0.02 |
-145%
|
Forward EV/OCF
Today’s price vs future operating cash flow
Peer Comparison
| Market Cap | EV/OCF | P/E | ||||
|---|---|---|---|---|---|---|
| CA |
|
MedMira Inc
OTC:MMIRF
|
42.1m USD | -26.6 | -12 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
170B USD | 54.2 | 59.7 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
160.6B USD | 16.7 | 25.3 | |
| US |
|
Stryker Corp
NYSE:SYK
|
126.1B USD | 27 | 38.6 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
107.5B USD | 17.3 | 23.1 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
97.4B USD | 22.6 | 32.3 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
40B EUR | 15.6 | 18.9 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
46.3B USD | 28 | 45.3 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
44.7B USD | 38.5 | 42.6 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
44.1B USD | 17.5 | 24.7 | |
| US |
|
Resmed Inc
NYSE:RMD
|
32B USD | 16.2 | 21.5 |
Market Distribution
| Min | 0 |
| 30th Percentile | 7.9 |
| Median | 11.9 |
| 70th Percentile | 19.5 |
| Max | 22 577.3 |
Other Multiples
MedMira Inc
Glance View
MedMira, Inc. is a biotechnology company, which through its subsidiaries, engages in the research, development, manufacture, and commercialization of diagnostics and technology platforms. The company is headquartered in Halifax, Nova Scotia. The firm is engaged in the development and commercialization of rapid diagnostics and technology platforms. The MedMira Rapid Vertical Flow (RVF) Technology platform is the basis for the Company's line of rapid tests. Its technology platform detects multiple biomarkers specific to several diseases using a single cartridge. Its Multiplo line of rapid tests for human immunodeficiency virus (HIV), Hepatitis B and C, and syphilis uses the platforms capabilities to deliver approximately up to four test results using one test cartridge and one drop of specimen. The company also has a research product line that facilitates technology licensing, contract manufacturing, and regulatory consulting. The firm sells its rapid tests through a network of medical distributors and strategic business development partners to customers in all sectors of the healthcare industry, including laboratories, hospitals and point-of-care clinics, among others.
